Omlyclo was originally approved in March 2025 in 2 single-dose prefilled syringe strengths: 75mg/0.5mL and 150mg/mL.

HealthDay News — A confidential internal memo from the US Food and Drug Administration (FDA) is creating new controversy around vaccine safety after an agency official said the COVID-19 vaccine may ...

HealthDay News — More than 69% of Medicaid enrollees with a new diagnosis of opioid use disorder (OUD) do not receive treatment within 180 days, according to a study published online November 23 in ...

HealthDay News — In a practice guideline issued by the American Society for Radiation Oncology and published online November 17 in Practical Radiation Oncology, recommendations are presented for the ...

Intensive behavioral therapy also recommended, including setting physical exercise and diet goals, energy intake restriction, weekly counseling.

Zilganersen is an investigational antisense oligonucleotide designed to block the product of excess GFAP caused by mutations in the GFAP gene.

ST-503 is a one-time dose, investigational epigenetic regulator that specifically targets and silences the SCN9A gene.

Earlier this year, Abraham urged Louisiana Senator Dr Bill Cassidy, a gastroenterologist who strongly supports childhood vaccines, to confirm Robert F. Kennedy Jr. as health secretary. The 2 men later ...

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for baxdrostat for the add-on treatment of uncontrolled or treatment resistant hypertension in ...

While the International Agency for Research on Cancer labels talc that may contain asbestos as “probably carcinogenic,” the mineral continues to fall under the FDA’s Generally Recognized As Safe (GRAS ...

HealthDay News — A growing list of pots and pans is now considered unsafe, and the US Food and Drug Administration (FDA) is urging people to check their kitchens and get rid of them right away. In a ...

If approved, the new autoinjector formulation would allow patients to administer furosemide at home reducing administration time from 5 hours to under 10 seconds.